Artikel ; Online: Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors.
Molecules (Basel, Switzerland)
2023 Band 28, Heft 13
Abstract: Psychostimulant use disorders (PSUD) affect a growing number of men and women and exert sizable public health and economic burdens on our global society. Notably, there are some sex differences in the onset of dependence, relapse rates, and treatment ... ...
| Abstract | Psychostimulant use disorders (PSUD) affect a growing number of men and women and exert sizable public health and economic burdens on our global society. Notably, there are some sex differences in the onset of dependence, relapse rates, and treatment success with PSUD observed in preclinical and clinical studies. The subtle sex differences observed in the behavioral aspects of PSUD may be associated with differences in the neurochemistry of the dopaminergic system between sexes. Preclinically, psychostimulants have been shown to increase synaptic dopamine (DA) levels and may downregulate the dopamine transporter (DAT). This effect is greatest in females during the high estradiol phase of the estrous cycle. Interestingly, women have been shown to be more likely to begin drug use at younger ages and report higher levels of desire to use cocaine than males. Even though there is currently no FDA-approved medication, modafinil, a DAT inhibitor approved for use in the treatment of narcolepsy and sleep disorders, has shown promise in the treatment of PSUD among specific populations of affected individuals. In this review, we highlight the therapeutic potential of modafinil and other atypical DAT inhibitors focusing on the lack of sex differences in the actions of these agents. |
|---|---|
| Mesh-Begriff(e) | Female ; Humans ; Male ; Dopamine Uptake Inhibitors/pharmacology ; Modafinil/therapeutic use ; Modafinil/pharmacology ; Sex Characteristics ; Benzhydryl Compounds/pharmacology ; Benzhydryl Compounds/therapeutic use ; Central Nervous System Stimulants/pharmacology ; Cocaine/pharmacology ; Dopamine |
| Chemische Substanzen | Dopamine Uptake Inhibitors ; Modafinil (R3UK8X3U3D) ; Benzhydryl Compounds ; Central Nervous System Stimulants ; Cocaine (I5Y540LHVR) ; Dopamine (VTD58H1Z2X) |
| Sprache | Englisch |
| Erscheinungsdatum | 2023-07-07 |
| Erscheinungsland | Switzerland |
| Dokumenttyp | Journal Article ; Review |
| ZDB-ID | 1413402-0 |
| ISSN | 1420-3049 ; 1431-5165 ; 1420-3049 |
| ISSN (online) | 1420-3049 |
| ISSN | 1431-5165 ; 1420-3049 |
| DOI | 10.3390/molecules28135270 |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.MO 81: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.